Enjeti AK, Fogler WE, Smith TAG, Lincz LF, et al. Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia. Br J Haematol 2024;204:2264-2274.
PMID: 38659295